Diet and drug combo aim to tame tumor side effects
Disease control
Terminated
This study tested a new drug called serabelisib combined with a diet that lowers insulin levels, with or without another chemotherapy drug, in people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The goal was to see if the diet could reduce sid…
Phase: PHASE1 • Sponsor: Faeth Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC